Triptolide induces apoptosis in human anaplastic thyroid carcinoma cells by a p53-independent but NF-κB-related mechanism

Oncology Reports

Volumn 22, Issue 6, 2009, Pages 1397-1401

  Zhu, Wenbo ^a   Hu, Haiyan ^b   Qiu, Pengxin ^a   Yan, Guangmei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Anaplastic thyroid carcinoma; Apoptosis; Nuclear factor B; p53; Triptolide

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; TRIPTOLIDE;

ANAPLASTIC CARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYROID CARCINOMA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NF-KAPPA B; PHENANTHRENES; THYROID NEOPLASMS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70449339746     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000580     Document Type: Article

References (26)

1. Neff RL, Farrar WB, Kloos RT and Burman KD: Anaplastic thyroid cancer. Endocrinol Metab Clin North Am 37: 525-538, 2008.
2. Pasieka JL: Anaplastic thyroid cancer. Curr Opin Oncol 15: 78-83, 2003.
3. McIver B, Hay ID, Giuffrida DF, et al: Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130: 1028-1034, 2001.
4. Ain KB: Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 8: 715-726, 1998.
5. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001.
6. Burlacu A: Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7: 249-257, 2003.
7. Hockenbery DM: bcl-2 in cancer, development and apoptosis. J Cell Sci (Suppl) 18: 51-55, 1994.
8. Bykov VJ and Wiman KG: Novel cancer therapy by reactivation of the p53 apoptosis pathway. Ann Med 35: 458-465, 2003.
9. Amundson SA, Myers TG and Fornace AJ Jr: Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17: 3287-3299, 1998.
10. Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208, 2004.
11. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
12. Tao X and Lipsky PE: The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 26: 29-50, 2000.
13. Shamon LA, Pezzuto JM, Graves JM, et al: Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett 112: 113-117, 1997.
14. Tengchaisri T, Chawengkirttikul R, Rachaphaew N, Reutrakul V, Sangsuwan R and Sirisinha S: Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett 133: 169-175, 1998.
15. Lee KY, Chang W, Qiu D, Kao PN and Rosen GD: PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J Biol Chem 274: 13451-13455, 1999.
16. Chan EW, Cheng SC, Sin FW and Xie Y: Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol Lett 122: 81-87, 2001.
17. Wang CY, Zhong WB, Chang TC, Lai SM and Tsai YF: Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB. Cancer 95: 1827-1833, 2002.
18. Reed JC: Apoptosis-targeted therapies for cancer. Cancer Cell 3: 17-22, 2003.
19. Kastan MB, Canman CE and Leonard CJ: P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14: 3-15, 1995.
20. Lee JM and Bernstein A: Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev 14: 149-161, 1995.
21. Yu Q: Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy. Drug Resist Update 9: 19-25, 2006.
22. Chang WT, Kang JJ, Lee KY, et al: Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem 276: 2221-2227, 2001.
23. Kuwana T and Newmeyer DD: Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15: 691-699, 2003.
24. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC and Fornace AJ Jr: An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 60: 6101-6110, 2000.
25. Ahmad A, Banerjee S, Wang Z, Kong D and Sarkar FH: Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. J Cell Biochem 105: 1461-1471, 2008.
26. Pozo-Guisado E, Merino JM, Mulero-Navarro S, et al: Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with down-regulation of Bcl-2 and NF-kappaB. Int J Cancer 115: 74-84, 2005.